Genor Biopharma Holdings Ltd operates as a biopharmaceutical company. The Company focuses on developing and commercializing oncology and autoimmune drugs. Genor Biopharma Holdings serves customers worldwide.

Next Day Disclosure Return

Announcements and Notices - [Very Substantial Acquisition / Issue of Shares under a Specific Mandate / Consideration Issue / Reverse Takeover / Announcement by Offeree Company under the Takeovers Code / Connected Transaction / Change of Company Name / Capital Reorganisation / Share Scheme]

Monthly Update On (1) Very Substantial Acquisition Involving Issue Of Consideration Shares Under Specific Mandate; (2) Reverse Takeover Involving The New Listing Application; (3) Application For Whitewash Waiver; (4) Special Deal; (5) Proposed Change Of Company Name; (6) Proposed Increase In Authorised Share Capital Of The Company; And (7) Proposed Adoption Of The One-Off Share Option Plan

Announcements and Notices - [Announcement by Offeree Company under the Takeovers Code / Connected Transaction]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genor Biopharma Holdings (6998 HK)

Next Day Disclosure Return

Appointment Of Independent Financial Adviser

Next Day Disclosure Return

(Revised) Next Day Disclosure Return

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)